LENZ Therapeutics, Inc.LENZNASDAQ
Loading
EBITDA Over TimeContracting
Percentile Rank50
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

Latest
$-65.51M
↓ 36% vs avg
Percentile
P50
Within normal range
Streak
1 yr
Consecutive declineContracting
Average
$-48.03M
Historical baseline
PeriodValueYoY Change
TTM$-65.51M-31.8%
2024$-49.71M+31.4%
2023$-72.41M-591.3%
2022$-10.47M+85.0%
2021$-70.03M-2.7%
2020$-68.21M-47847.4%
2019$142860.00-